Key Findings

Find a parent-focused resource outlining some of our biggest findings in the first 5 years of COMBO. 

So far, COMBO’s results are reassuring: 

  • There does not seem to be any significant developmental effect on babies whose moms had Covid during pregnancy. These babies:
    • Are developing just as well as other babies in learning & understanding, language, and movement (aspects of brain development) through the first year of life
    • Are not at greater risk for hearing loss (as babies or as toddlers) 
    • Have similar temperaments (at 6 months old) as babies who were not exposed during pregnancy, including being able to regulate their own emotions and behavior at an age-appropriate level 
  • Mothers have an extremely low risk (~2%) of transmitting COVID to their babies during pregnancy, after birth, or while breastfeeding.
    • This finding was a groundbreaking step in confirming the safety of mothers and infants “rooming-in” together postpartum and breastfeeding, both of which are known to be highly beneficial for mother and child. 
    • Whereas the start of the pandemic saw newborns separated from their mothers for fear of transmitting the virus, there has been a turnaround in hospital policy at the national and global level. 
    • Because of this policy reform, Dr. Dumitriu was asked to collaborate on a Dear Colleagues Letter to Senate leaders
      • The letter laid out scientific reasons for funding to be directed to unfunded research areas, including child development and mental health
      • This letter ultimately helped infuse $1.5 billion into the research initiative that became the RECOVER Initiative

Key findings for children born 2020-2022 

While prenatal exposure to the Covid-19 virus does not seem to be impacting children’s development, COMBO is seeing some differences in neurodevelopmental outcomes for babies born from 2020-2022, whether or not their mothers had Covid in pregnancy, making stress from social disruption a key area of focus: 

As quoted in the New York Times, Dr. Dumitriu asserts, “It is absolutely possible for these children to catch up, if we catch things early. There is nothing deterministic about a brain at six months.” To identify early opportunities for intervention, continuing to follow these children is essential

Dr. Dumitriu says, “It’s important to note that we're not looking at autism diagnosis here. We're looking at autism risk, based on parent report. It’s too early to have definitive diagnostic numbers. But this screen is predictive, and it’s not showing that prenatal exposure to Covid or the pandemic increases the likelihood for autism.” 

Key findings for mothers who gave birth in 2020 

Upcoming protocols for this cohort 

  • While COMBO continues to enroll pregnant mothers, the original COMBO cohort children are turning 4 & 5 this year. The data so far show that this generation may be slower to reach some developmental milestones, with ongoing potential for future neurodevelopmental findings. 
  • For example, while these children are not screening positive for a higher risk of autism, Dr. Dumitriu says that “doesn't mean we might not see jumps in other areas. The risk of various neurodevelopmental conditions changes based on different insults, so there's still a risk that we might see increases in ADHD, depression, anxiety, and (later on) schizophrenia. Continued long-term monitoring is important for primary prevention and early intervention.” 
  • Given this, and with school readiness on the horizon for this cohort, COMBO’s study protocols are transitioning more fully into an ERH focus, with key developmental assessments, including: 
    • Social & emotional skills 
    • Fine & gross motor skills 
    • Cognition and language 
    • Memory 
    • Behavioral regulation 
    • Emotional & biobehavioral synchrony